Teragen Etex announced on the 23rd that it will additionally acquire 1,831,039 shares of MedPacto, a medical and pharmaceutical research and development company, for approximately 12 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
